Literature DB >> 1871980

Structural variation of La Crosse virions under different chemical and physical conditions.

G J Wang1, M Hewlett, W Chiu.   

Abstract

La Crosse (LAC) virions exposed to different pHs (7.3, 6.2, and 5.4) and temperatures (37 degrees, 20 degrees, and 4 degrees) were preserved in thin layers of vitreous ice and observed by electron cryomicroscopy. Our results indicate that, at lower pH, virus particles interact with each other to form aggregates. In some cases, particles could be interpreted to have fused together. At neutral pH and higher temperatures morphological changes consistent with deformation in some particles were observed. We suggest that low pH conditions are sufficient for membrane fusion events to occur with LAC virions.

Mesh:

Year:  1991        PMID: 1871980     DOI: 10.1016/0042-6822(91)90869-d

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

1.  Complementarity in the supramolecular design of arenaviruses and retroviruses revealed by electron cryomicroscopy and image analysis.

Authors:  Benjamin W Neuman; Brian D Adair; John W Burns; Ronald A Milligan; Michael J Buchmeier; Mark Yeager
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

2.  Insights into bunyavirus architecture from electron cryotomography of Uukuniemi virus.

Authors:  A K Overby; R F Pettersson; K Grünewald; J T Huiskonen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

3.  Ultrastructure of SARS-CoV, FIPV, and MHV revealed by electron cryomicroscopy.

Authors:  Benjamin W Neuman; Brian D Adair; Craig Yoshioka; Joel D Quispe; Ronald A Milligan; Mark Yeager; Michael J Buchmeier
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

4.  Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein.

Authors:  S M de Boer; J Kortekaas; L Spel; P J M Rottier; R J M Moormann; B J Bosch
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.